Related Experiment Video
Updated: Jul 11, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
[Recent examples for drug (developments) in primary, secondary and tertiary prevention]
P Bramlage1, C Schindler, A C Schmidt
1Institut für Klinische Pharmakologie, Medizinische Fakultät Carl-Gustav-Carus, Technische Universität Dresden, Fiedlerstrasse 27, 01307 Dresden, Deutschland. peter.bramlage@mailbox.tu-dresden.de
Deutsche Medizinische Wochenschrift (1946)
|October 11, 2007
Summary
Disease prevention strategies, including lifestyle changes and pharmacotherapy, are crucial in public health and medicine. New drug developments offer exciting options for reducing risk factors, particularly for conditions like acute myocardial infarction.
Area of Science:
- Public Health and Clinical Medicine
- Cardiovascular Disease Prevention
Background:
- Disease prevention is a central theme in public health and clinical medicine.
- Interventions include population-wide strategies, lifestyle modifications, and pharmacotherapy.
Purpose of the Study:
- To illustrate risk factor targeting using acute myocardial infarction as an example.
- To review new pharmacotherapies in development and their potential impact.
- To discuss the efficacy of current treatments and areas needing further intervention.
Main Methods:
- Review of disease prevention strategies in public health and clinical medicine.
- Case study analysis focusing on acute myocardial infarction risk factors.
- Evaluation of new drug development pipelines and clinical trial phases.
- Assessment of interventions targeting physicians and patients for improved pharmacotherapy efficacy.
Main Results:
- Significant advancements and new drug options are emerging for risk factor reduction.
- For conditions like arterial hypertension, new drug development may not significantly improve outcomes.
- Current pharmacotherapy efficacy can be enhanced through targeted physician and patient interventions.
Conclusions:
- New pharmacotherapies show promise for reducing risk factors, exemplified by acute myocardial infarction.
- Further interventions are needed for conditions like arterial hypertension where drug development is limited.
- Improving physician adherence to guidelines and patient compliance is key to optimizing existing treatments.
Related Concept Videos
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:26Levels of Health Promotion and Illness Prevention
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...